Medline OverviewTrack Medline's EBIT ($1.8B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
The latest EBIT for MDLN is $1.8B as of June 2026. That is above the sector sector average of $-6.4M. Investors often review this figure alongside Medline's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, MDLN currently prints $1.8B for EBIT, while the sector average sits near $-6.4M. That is roughly 28574.4% above the sector mean. Large gaps often invite a closer look at Medline's growth, margins, and balance sheet.
A EBIT figure of $1.8B for MDLN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-6.4M. Explore the charts below for those layers of context.
After noting MDLN's EBIT ($1.8B), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
